Brief: Longboard Pharma- Expects To Report Its Cash, Cash Equivalents And Short-Term Investments Were About $48 Million
02/01/2024 21:07
Jan 2 (Reuters) - Longboard Pharmaceuticals Inc
LBPH.O :
* LONGBOARD PHARMACEUTICALS- EXPECTS TO REPORT THAT ITS
CASH, CASH
EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF DEC 31, 2023 WERE
ABOUT $48 MILLION
Further company coverage: LBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions